Clinical Trial Update: A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia [Phase 2, Phase 3]

View source ↗

Summary

This Clinical Trials entry describes a multicohort randomized study evaluating new immunotherapies and allogeneic hematopoietic stem cell transplantation as fro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Lymphoblastic Leukemia | Phase 2, Phase 3 | Status: RECRUITING